SK Inc. Accelerates Investments in the Global Alternative Food Market with Expanded Investment in Perfect Day, Inc.
SK Inc. becomes second-largest shareholder of the Center for Breakthrough Medicines, a U.S.-based Cell and Gene Therapy (CGT) CDMO, accelerating its growth as a global leader in the field
SK Inc. Biopharm Investment and Sister Company Sign Collaborations to Advance Promising Area of Drug Development
SK Inc. Invests in Perfect Day’s Series D Funding Round, Accelerating its Expansion into the New Food Space